New diphenylphosphane derivatives of ketoconazole are promising antifungal agents.
Rodrigo F M de AlmeidaFilipa C SantosKrzysztof MaryczMichalina AlickaAnna KrasowskaJakub SuchodolskiJarosław Jan PanekAneta JezierskaRadosław StarostaPublished in: Scientific reports (2019)
Four new derivatives of ketoconazole (Ke) were synthesized: diphenylphosphane (KeP), and phosphane chalcogenides: oxide (KeOP), sulphide (KeSP) and selenide (KeSeP). These compounds proved to be promising antifungal compounds towards Saccharomyces cerevisiae and Candida albicans, especially in synergy with fluconazole. Simulations of docking to the cytochrome P450 14α-demethylase (azoles' primary molecular target) proved that the new Ke derivatives are capable of inhibiting this enzyme by binding to the active site. Cytotoxicity towards hACSs (human adipose-derived stromal cells) of the individual compounds was studied and the IC50 values were higher than the MIC50 for C. albicans and S. cerevisiae. KeP and KeOP increased the level of the p21 gene transcript but did not change the level of p53 gene transcript, a major regulator of apoptosis, and decreased the mitochondrial membrane potential. Taken together, the results advocate that the new ketoconazole derivatives have a similar mechanism of action and block the lanosterol 14α-demethylase and thus inhibit the production of ergosterol in C. albicans membranes.
Keyphrases
- candida albicans
- biofilm formation
- saccharomyces cerevisiae
- oxidative stress
- structure activity relationship
- molecular dynamics
- endothelial cells
- copy number
- genome wide
- endoplasmic reticulum stress
- gene expression
- single molecule
- climate change
- small molecule
- risk assessment
- pluripotent stem cells
- single cell
- genome wide analysis